Medtech financings for July (to date) stand at nearly $375 million

Financings at medical technology companies for July to date stand at $373.7 million.  Companies included are those in MedMarket Diligence’s area of focus:  medical device and complementary or directly competing companies.

Below are the individual companies included, ranked by the amount financed at each. 

Financing amount

Company (technology focus)

$108.00

Small Bone Innovations, Inc., raises record $108 million in Series D financing (technologies and treatments for small bones and joints)

$50.00

ConforMIS Inc. has raised $50 million (custom knee implants and instrumentation)

$42.00

Oraya Therapeutics has raised $42 million in Series C financing (radiosurgical treatments for eye diseases)

$21.50

Paradigm Spine has closed on $21.5 million in debt and equity financing (non-fusion spinal implants)

$21.20

Symetis SA raises $21.2 million to fund clinical trials (percutaneous valve replacement system)

$20.00

Relievant Medsystems Announces Completion of $20 Million Financing (nerve ablation for treatment of low back pain)

$18.95

Novasys Medical has received $18.95 million in the second tranche of its fourth round of funding (treatment of stress urinary incontinence)

$15.00

Lumenis Ltd has received a $15 million equity financing (RF and light-based ablation devices)

$13.50

BeneChill has raised $13.5 million in Series C funding (therapeutic hypothermia device for cardiac arrest, stroke, and head injury)

$11.60

Cardiorobotics has raised $11.6 million in an undisclosed financing round (remotely operated minimally invasive probe used in heart and other surgery)

$10.00

NICO Corp. has raised $10 million in a Series C financing round (minimally invasive removal of tumors from brain and central nervous system tissue)

$8.10

Chase Medical, Inc., has received $8.1 million of a planned $9.1 million financing round (device used during treatment of congestive heart failure)

$7.60

Vidacare Corp. has raised $7.6 million in a Series D1 financing round (intraosseous drug and fluid delivery)

$7.50

EndoGastric Solutions has raised $7.5 million (endoscopic treatment of gastroesophageal reflux and obesity)

$4.70

Augmenix, Inc., has raised $4.7 million out of a potential $7.5 million undisclosed equity financing round (hydrogel spacers for use in radiation oncology)

$4.00

SpineGuard S.A. raises $4 million, completing a $15 million first round funding that began with an $11 million round in April (pedicle screw replacement in spine surgery)

$4.00

SafeStitch Medical, Inc., has entered into two stock purchase agreements with private investors worth $9 million (endoscopic surgical devices)

$2.80

NeoChord, Inc., has raised $2.8 million in a Series A financing (device for repair of mitral valve regurgitation)

$2.50

TransMedics, Inc., has raised $2.5 million in a debt offering (organ transplant support technologies)

$0.75

TriVirix International has raised $750K out of a planned $1.4 million Series C round (contract device manufacturer)

$373.70

Total

 

Leave a Reply